ClinicalTrials.gg
CompletedNCT05340517Updated Apr 22, 2022

Prospective Study of Video-assisted Rib Planting in Chest Wall Stabilization

An interventional study of video-assisted rib planting in Rib Fractures and Rib Fracture Multiple, sponsored by Weigang Zhao. Completed at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-04-22.

Sponsored by Weigang Zhao · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Feb 2021, registered Feb 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The purpose of this study is to compare the advantages and disadvantages of video-assisted rib planting and traditional internal fixation of rib fractures in chest wall stabilization.

The investigators design a new surgical method of video-assisted thoracoscopic surgery for rib fractures, evaluate the advantages and disadvantages of the new surgical techniques with a prospective study.

02

Conditions studied

  • Rib Fractures
  • Rib Fracture Multiple

Browse trials for

Keywords

  • internal fixation
  • video-assisted
  • chest wall stabilization
  • prospective study
03

In context

Rib Fractures

126 studies on the registry are indexed under Rib Fractures; 28 are open to participants now.

This study's enrollment of 20 is below the median of 60 across 92 interventional studies indexed under Rib Fractures.

Browse Rib Fractures studies →

Lead sponsor

This is the only study on the registry with Weigang Zhao as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-≥3 unilateral rib displacement fractures

  • 18-70 years old
  • I-II
  • Preoperative arterial oxygen partial pressure >60mmHg
  • Carbon dioxide partial pressure \<50mmHg

Exclusion criteria

Exclusion Criteria:

  • The distance from the broken end of the posterior rib fracture to the spine is less than 2cm
  • Airway stenosis
  • Abnormal coagulation system
  • History of peptic ulcer or bleeding
  • History of allergy to anesthesia related drugs
  • History of asthma or chronic obstructive pulmonary emphysema
  • Pregnant women
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    video-assisted rib planting

    Procedure: video-assisted rib planting

Interventions

  • Procedurevideo-assisted rib planting

    Give the patient intercostal nerve block and laryngeal mask anesthesia, after that, put the patient in lateral position. Make a 4-6cm posterolateral incision along the lower edge of the scapula,sever latissimus dorsi and serratus anterior and reach the rib surface. Lift the scapula with the abdominal retractor (or xiphoid retractor), Free adhesion tissue inside the scapula and put in the thoracoscopic lens. Free the tissue of the upper and lower edges of the ribs carefully, reset ribs and insert rib plate, which is fixed by 90° electric drill and locking screw.

    Also known as: video-assisted thoracoscopic surgery for rib fractures

06

What researchers measure

Primary outcomes

  1. The pain score after operation

    The investigators evaluate and record the patients' pain score after operation by visual analog scale (VAS),which is used to evaluate pain scores 6h,12h,and 24h after the operation. 0-10 is used to represent different degrees of pain, 0 is painless and 10 is severe pain. The grading criteria of pain were: 0: no pain; 1-3: mild pain; 4-6: moderate pain; 7-10: severe pain.

    Time frame: 6 hours after operation

  2. The pain score after operation

    The investigators evaluate and record the patients' pain score after operation by visual analog scale (VAS). 0-10 is used to represent different degrees of pain, 0 is painless and 10 is severe pain. The grading criteria of pain were: 0: no pain; 1-3: mild pain; 4-6: moderate pain; 7-10: severe pain.

    Time frame: 12 hours after operation

  3. The pain score after operation

    The investigators evaluate and record the patients' pain score after operation by visual analog scale (VAS). 0-10 is used to represent different degrees of pain, 0 is painless and 10 is severe pain. The grading criteria of pain were: 0: no pain; 1-3: mild pain; 4-6: moderate pain; 7-10: severe pain.

    Time frame: 24 hours after operation

Secondary outcomes

  1. The postoperative drainage

    The investigators record the postoperative drainage of patients.The drainage of chest catheter or negative pressure ball was recorded by the nurse every day after surgery. Less postoperative drainage means faster recovery and shorter discharge times.

    Time frame: 7 days at most

Other outcomes

  1. The operation time

    The investigators record patients' operation time duration.

    Time frame: During surgery

  2. The length of incision

    The investigators record the length of operative incision.

    Time frame: During surgery

  3. The intraoperative bleeding

    The investigators record the intraoperative bleeding of patients.

    Time frame: During surgery

  4. The treatment costs

    The investigators record the treatment costs and calculate per capita treatment costs of patients,which is recorded and counted at the time of discharge. Total treatment costs include hospitalization, treatment, surgery, medications, and other related expenses.

    Time frame: from the date of hospitalization to the date of leave hospital,assessed up to 100 months

  5. Days of stay hospital

    Days of stay hospital

    Time frame: from the date of hospitalization to the date of leave hospital,assessed up to 100 months

07

Study locations

1 site
  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital
    Shanghai, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2021 to primary completion in Apr 2021, 2 months.

Of 41 non-industry interventional studies with no phase under Rib Fractures, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 37. This study's 2 months is below that.

Counting every sponsor, half of 41 studies reached it within 23 months; a quarter within 15 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 14, 2022
First posted
Apr 22, 2022
StartActual
Feb 22, 2021
Primary completionActual
Apr 30, 2021
CompletionActual
Jan 6, 2022
Last update
Apr 22, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05340517
Lead sponsor
Weigang Zhao
Responsible party
Weigang Zhao (Clinical Professor, Shanghai Jiao Tong University Affiliated Sixth People's Hospital) — Sponsor-investigator
First posted
Apr 22, 2022
Start date
Feb 22, 2021
Primary completion
Apr 30, 2021
Completion
Jan 6, 2022
Last update
Apr 22, 2022

Study contacts

Weigang Zhao
principal investigator · Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion